Bio-Rad Laboratories | BIO - Net Income


Bio-Rad Laboratories reported $371.4M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Abbott USD 920M 8M Sep/2026
Agilent USD 362M 23M Jun/2026
Becton, Dickinson and Co. USD 696M 319M Sep/2026
Bio Techne USD 28.29M 26.33M Sep/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Bruker USD -122.8M 59.9M Sep/2026
Charles River Laboratories USD 333.07M 334.55M Sep/2026
Danaher USD 1.24B 365M Sep/2026
General Electric Aerospace USD 2.29B 82M Sep/2026
Illumina USD 220M 13M Sep/2026
IQVIA Holdings USD 350M 94M Sep/2026
Laboratory Of America USD 262.8M 35.9M Sep/2026
Merck USD 5.07B 6.4B Sep/2026
Mettler Toledo International USD 245.95M 13.05M Sep/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 312M 8M Sep/2026
Repligen USD -38.43M 43.44M Sep/2026
Revvity USD 62.3M 10.48M Sep/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Siemens EUR 2.27B 243M Jun/2026
Standard Biotools USD -26.76M 153.83M Jun/2026
Thermo Fisher Scientific USD 1.72B 15M Sep/2026
Tosoh JPY 7.31B 12.15B Sep/2026
Waters USD -136M 64M Jun/2026